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OBJECTIVES To determine the prevalence and clinical significance of early ST segment elevation resolution
after primary percutaneous transluminal coronary angioplasty (PTCA) for acute myocardial
infarction (AMI).
BACKGROUND Despite angiographically successful restoration of coronary flow early during AMI, adequate
myocardial reperfusion might not occur in a substantial portion of the jeopardized myocar-
dium due to microvascular damage. This phenomenon comprises the potentially beneficial
effect of early recanalization of the infarct related artery (IRA).
METHODS Included in the study were 117 consecutive patients who underwent angiographically
successful [Thrombolysis in Myocardial Infarction (TIMI III)] primary PTCA. The patients
were classified based on the presence or absence of reduction $50% in ST segment elevation
in an ECG performed immediately upon return to the intensive cardiac care unit after the
PTCA in comparison with ECG before the intervention.
RESULTS Eighty-nine patients (76%) had early ST segment elevation resolution (Group A) and 28
patients (24%) did not (Group B). Group A and B had similar clinical and hemodynamic
features before referring to primary PTCA, as well as similar angiographic results. Despite
this, ST segment elevation resolution was associated with better predischarge left ventricular
ejection fraction (LVEF) (44.7 6 8.0 vs. 38.2 6 8.5, p , 0.01). Group B patients, as
compared with those of Group A, had a higher incidence of in-hospital mortality (11% vs.
2%, p 5 0.088), congestive heart failure (CHF) [28% vs. 19%, odds ratio (OR) 5 4, 95%
confidence interval (CI) 1 to 15, p 5 0.04], higher long-term mortality (OR 5 7.3, 95% CI
1.9 to 28, p 5 0.004 with Cox proportional hazard regression analysis) and long-term CHF
rate (OR 5 6.5, 95% CI 1.3 to 33, p 5 0.016 with logistic regression).
CONCLUSIONS Absence of early ST segment elevation resolution after angiographically successful primary
PTCA identifies patients who are less likely to benefit from the early restoration of flow in
the IRA, probably because of microvascular damage and subsequently less myocardial salvage.
(J Am Coll Cardiol 1999;34:1932–8) © 1999 by the American College of Cardiology
In acute myocardial infarction (AMI) patients who are
treated with thrombolytic therapy, early resolution of ST
segment elevation is associated with early restoration of
coronary blood flow (1–4) and, consequently, smaller infarct
size (1,4–6) and better clinical outcome (5–6). When early
reperfusion is attempted by primary percutaneous translu-
minal coronary angioplasty (PTCA), the flow pattern in the
infarct related artery (IRA) is routinely recorded at the end
of the intervention. However, in previous myocardial con-
trast echo (MCE) (7–13), scintographic (14–15) and MRI
(16) studies, it was shown that even early restoration of the
Thrombolysis in Myocardial Infarction (TIMI) grade III
flow in the IRA (either by thrombolysis or primary PTCA)
was not always associated with myocardial reperfusion due
to microvascular damage. This pathologic process, which
was termed the “no-reflow” phenomenon, significantly
comprises the beneficial effect of early recanalization of the
IRA during AMI (7–10,12,16–18). We postulated that
early changes in the ST segment elevation, which reflect the
electrical changes in the jeopardized myocardium itself,
might provide important information regarding myocardial
reperfusion after primary PTCA. The objective of this study
was to determine the prevalence and clinical significance of
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early ST segment elevation resolution after angiographically
successful primary PTCA.
METHODS
Study population. The study population consisted of con-
secutive AMI patients who underwent primary PTCA and
complied with the following criteria: 1) ST segment eleva-
tion $2 mm in at least two contiguous leads on the
admission ECG, 2) absence of significant ST segment
elevation resolution before the PTCA, 3) achievement of
TIMI grade III flow with ,50% stenosis in the IRA. The
diagnosis of AMI was made on the basis of ischemic chest
pain lasting at least 30 min and ST segment elevation in at
least two contiguous leads. Acute myocardial infarction
patients who were eligible for reperfusion therapy were
treated with PTCA whenever one of the following condi-
tions existed: 1) contraindication to thrombolytic therapy,
2) Killip $2 on admission, 3) hemodynamic instability
(regardless of infarct site), 4) any extensive anterior wall MI,
if PTCA was feasible within 1 h of admission. Otherwise
the patients were treated with thrombolytic therapy. Be-
tween 1994 and 1996, 155 patients with ST segment
elevation AMI were referred for primary PTCA based on
the above mentioned criteria. In nine patients the ST
segment elevation resolved by 50% or more in sequential
ECG’s before the PTCA. In 11 patients the flow in IRA
could be restored but TIMI III was not achieved, and four
other patients were referred for emergent coronary artery
bypass graft for diffuse and severe coronary artery disease
(CAD). In 14 patients ECG was not repeated immediately
after the PTCA. The remaining 117 patients were enrolled
in this study.
ECG. The sum of ST segment elevation in the three
contiguous leads with the highest ST segment elevation
((ST) was calculated in two ECG’s: the latest ECG which
was performed (#30 min) before the PTCA and the first
ECG after the intervention on return to the intensive
cardiac care unit (ICCU). The ST segment elevation was
measured 0.08 s after the J point by two investigators who
were unaware of the clinical and angiographic findings. A
reduction of at least 50% in the (ST segment elevation
between the pre- and post-PTCA ECG’s was considered as
significant ST segment elevation resolution.
Coronary angiography. Coronary angiography and pri-
mary PTCA were performed in a routine manner. The first
balloon inflation was performed on the average 3.3 6 3 h
(median 3.25 h [2.3, 4.5]) after the onset of chest pain.
Angioplasty was repeated to restore normal (TIMI III) flow
in the IRA and reduce the degree of residual stenosis to less
than 30%. The final angiogram was evaluated for the
residual stenosis in the IRA by the quantitative coronary
angiography technique. When this angiographic goal could
not be accomplished by PTCA or was complicated by
dissection or reocclusion, stents were employed. The flow in
the IRA on the initial diagnostic angiogram and in that
obtained after completion of the intervention were classified
using the TIMI criteria. All angiograms were interpreted by
two angiographers who were blinded to changes in ST
segment elevation and to the clinical outcomes. All patients
were treated with aspirin (250 mg/day) and after stent
placement were treated with ticlopidine (500 mg/day) for
four weeks.
Echocardiographic technique. A commercially available
echocardiographic system (Hewlett-Packard Sonos 1500;
Hewlett-Packard Co., Andover, Massachusetts) employing
a 2.5 MHz transducer was used in this study. Patients
received a complete standard Doppler-echocardiographic
examination prior to hospital discharge. Left ventricular
ejection fraction (LVEF) was visually estimated (19) by an
echocardiographer unaware of the early changes in ST
segment elevation and the angiographic results.
Clinical follow-up. All patients were prospectively fol-
lowed during the hospital stay for the occurrence of the
following adverse events: congestive heart failure (CHF),
reinfarction, recurrent angina and death. Congestive heart
failure was defined by the presence of symptoms or signs of
pulmonary congestion or the need for diuretic treatment in
order to control such symptoms. Reinfarction was diag-
nosed based on the recurrence of persistent ischemic chest
pain followed by at least two-fold reelevation of creatine
kinase (CK) from the last measured value. Any recurrent
chest pain which was accompanied by ST-T segment
changes on the ECG was considered as recurrent angina if
reinfarction was ruled out. The combined end point of
mortality or CHF was considered a priori. For all patients’
mortality, data were obtained from the Israeli population
registry at the Ministry of the Interior. Fifty-five of the
patients were followed up periodically in our out-patient
clinic. The patients were examined at least once every 6
months or more frequently when clinically required. For
those patients, the long-term occurrence of CHF, recurrent
angina and reinfarction were recorded, using the same
definitions used for events during hospital stay.
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
CAD 5 coronary artery disease
CHF 5 congestive heart failure
CK 5 creatine kinase
IABP 5 intra-aortic balloon pulsation
ICCU 5 intensive cardiac care unit
IRA 5 infarct related artery
LV 5 left ventricle
LVEF 5 left ventricular ejection fraction
MCE 5 myocardial contrast echo
PTCA 5 percutaneous transluminal coronary angioplasty
TIMI 5 Thrombolysis in Myocardial Infarction
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Statistical methods. In the comparison of patients with
and without early ST segment elevation resolution, the
differences in parametric variables were assessed by the
Pearson chi-square test when the minimal expected number
of observations was more than five and Fisher exact test was
used otherwise. Continuous variables are presented as
mean 6 standard deviation and median (Q1, Q3) where Q1
and Q3 are the first and the third quartiles respectively. For
the comparison of continuous variables, a t test was used
when the distribution was normal and otherwise the Wil-
coxon rank test was used. Multivariate analysis of binary
outcomes independent of their time occurrence during the
follow-up period (in-hospital CHF, long-term CHF, one-
year mortality) was performed by logistic regression, and
Cox proportional hazard regression was used in multivariate
analysis of long-term mortality where the occurrence time
was considered. The multivariate analysis was performed in
two stages. In the initial step, we performed a forward
stepwise regression of all variables which had a p value
,0.25 in the univariant analysis or of known clinical
importance (age, gender, risk factors for CAD, previous MI,
MI location, time elapsed from symptom onset to PTCA,
Killip class, (ST segment elevation, pre-MI treatments, use
of catecholamines before PTCA and intra-aortic balloon
pulsation (IABP), multivessel CAD on angiography, stent
placement). In the second step, we achieved the final best
model by performing backward stepwise regression of the
variables selected in the initial step.
RESULTS
The first ECG after the primary PTCA was performed
immediately upon the return of the patients to the ICCU,
on the average 1.44 6 0.62 h (median 1.3 h [1, 1.7]) after
the first balloon inflation. Figure 1 describes the spectrum of
ST segment elevation resolution in the entire study popu-
lation. Based on this ECG, 89 patients (76%) had early
resolution of ST segment elevation (group A) and 28
patients (24%) did not (group B).
Baseline characteristics. The patients in group A, as
compared with those in group B, had a somewhat greater
incidence of hypertension (37% vs. 18%, p 5 0.096) and
previous MI (36% vs. 18%, p 5 0.12), and lesser prevalence
of diabetes mellitus (19% vs. 32%, p 5 0.24). Otherwise the
patients in both groups were similar with respect to age,
gender, other risk factors for CAD and cardiovascular
history (Table 1).
More patients in group A as compared with group B were
treated with beta-adrenergic blocking agents (26% vs. 0%,
p 5 0.0064) and aspirin (42% vs. 14%, p 5 0.015) prior to
the qualifying AMI. There were no differences in the
prevalence of patients who were on calcium channel block-
ers (19% vs. 11%, p 5 0.4) or nitrates (21% vs. 7%, p 5
0.15). However, in multivariate analysis, which controlled
for previous cardiovascular history and risk factors for CAD,
the prior medical treatment was not a significant predictor
of ST segment elevation resolution.
Clinical characteristics before the performance of pri-
mary PTCA. The patients in group A and group B were
also comparable with respect to clinical and hemodynamic
characteristics on admission and prior to the performance of
primary PTCA (Table 2). The two groups were similar with
respect to distribution of infarct site (anterior vs. inferior),
heart rate, blood pressure and Killip class on admission, as
well as with regard to the need for mechanical ventilation,
catecholamine treatment and IABP before or during the
intervention. Group A patients as compared with group B
patients had, although not statistically significant, a shorter
time interval from onset of symptoms to ICCU admission
(1.2 6 7.5 h vs. 2.96 6 3.2 h, median 1.7 h [1.2, 2.8] vs. 2 h
(1, 3) p 5 0.25) and, as a result, shorter interval to primary
PTCA (3.56 6 2.0 h vs. 4.46 6 3.4 h, median 3 h [2.3, 4.5]
vs. 4 h (2.5, 4.3) p 5 0.22). The time interval from primary
PTCA (first balloon inflation) to the recording of the first
ECG after the intervention was similar in group A and
Group B (1.48 6 0.62 h vs. 1.29 6 0.99 h, median 1.3 h
[1, 1.9] vs. 1.3 h (0.8, 1.7) p 5 0.24).
Angiographic characteristics. On the initial diagnostic
angiogram TIMI flow $2 was demonstrated in the IRA in
25 (25%) and 5 (18%) patients of groups A and B,
respectively (p 5 0.4). The patients in both groups also had
similar prevalence of multivessel CAD (52% vs. 43% in
group A and group B, respectively, p 5 ns), similar rate of
dissection as a complication of the PTCA (8% vs. 9%, p 5
0.56) and, in a similar number, a stent was placed in the
IRA (22% vs. 19%, p 5 0.94).
Figure 1. The distribution of the entire study population accord-
ing to the extent of ST segment elevation resolution immediately
after the primary PTCA, expressed as percentage decrease of the
(ST segment elevation before the procedure. In five patients there
was further ST segment elevation reelevation after the procedure
which is presented as negative numbers.
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Left ventricular function evaluation. Pre-hospital dis-
charge echocardiographic study technically suitable for es-
timating LVEF was available in 80 survivors of group A
(92%) and in 23 survivors of group B (92%). Early ST
segment elevation resolution was associated with higher
predischarge LVEF (44.7 6 8.0% vs. 38.2 6 8.5% median
44.5% [38, 50] vs. 39% [30, 46] for group A and group B,
respectively p , 0.01). In agreement, group A as compared
with group B patients also tended to have lower peak CK
value (1072 6 1090 IU vs. 1209 6 838 IU median 681 IU
[387, 1400] vs. 881.5 IU [640, 1490] p 5 0.11). Among the
55 patients who were followed in our outpatient clinic, 32
patients (58%) had repeated echocardiographic examination
within the first six months after discharge (23 belonged to
group A and 9 to group B). While the average change in
LVEF in group A was 3.3 6 7.6, in group B it was only
0.2 6 0.12 (p 5 0.18).
In-hospital clinical outcome (Fig. 2). Early ST segment
elevation resolution was associated in univariate analysis
with a trend towards lower prevalence of CHF (19% vs. 28%
in group A and B, respectively, p 5 0.11) and lower
mortality (2% vs. 11%, p 5 0.088). There were no differ-
ences in the prevalence of recurrent angina (17% vs. 19%,
p 5 1.0) and none of the patients in either group had
reinfarction. In multivariate analysis with adjustment for
age, gender, risk factors for CAD, previous MI, medical
therapy prior to the AMI and before the PTCA, MI
location, Killip class, IABP placement and multivessel
CAD on angiography, the absence of early ST segment
elevation resolution was a significant and independent
predictor of a higher rate of CHF (OR 5 4, 95% CI 1 to 15,
p 5 0.04) and of the combined end point CHF or mortality
(OR 5 3.5, 95% CI 1 to 12, p , 0.05). In the best final
model, in addition to early ST segment elevation resolution,
only treatment with catecholamines before the PTCA, time
to PTCA and IABP placement were independent correlates
of CHF. Age, time to PTCA and need for mechanical
ventilation were the independent predictors for mortality
and CHF in addition to ST segment elevation resolution.
Because of the small number of patients who died during
hospitalization, we did not perform multivariate analysis for
mortality. Although the prevalence of early ST segment
Table 1. Baseline Characteristics
Early ST Segment Elevation
Resolution N 5 89
(Group A)
No Early ST Segment
Elevation Resolution
N 5 28 (Group B)
p
Value
Age 57.5 6 14.5 58.7 6 12 0.7
Gender: Male 65 (73%) 21 (75%) 1.0
Risk Factors
Smoking 41 (46%) 13 (46%) 1.0
Hypertension 33 (37%) 5 (18%) 0.096
Diabetes mellitus 17 (19%) 9 (32%) 0.24
Hypercholesterolemia 35 (39%) 6 (21%) 0.13
Family history of CAD 34 (38%) 9 (32%) 0.72
Cardiovascular History
Previous MI 32 (36%) 5 (18%) 0.12
Previous angina 43 (48%) 10 (37%) 0.42
Previous CVA 6 (7%) 3 (11%) 0.44
Table 2. Clinical and Hemodynamic Characteristics Prior to the Performance of Primary PTCA
Early ST Segment
Elevation Resolution
N 5 89
(Group A)
No Early ST Segment
Elevation Resolution
N 5 28
(Group B)
p
Value
AMI location:
Anterior 55 (62%) 18 (64%) 0.98
Admission heart rate 77 6 21 79 6 20 0.65
Admission blood pressure 125 6 32 130 6 34 0.54
Killip I 59 (66%) 17 (61%) 0.8
Killip IV 16 (18%) 5 (18%) 1.0
Mean Killip class 1.78 6 1.2 1.82 6 1.2 0.86
IABP 40 (45%) 10 (36%) 0.52
Mechanical ventilation 18 (20.5%) 5 (18%) 0.98
Catecholamine administration 13 (15%) 5 (18%) 0.76
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elevation resolution was not influenced by the Killip class on
admission (entire study population: 76%, Killip II–IV: 73%,
Killip III–IV: 77% and Killip IV: 76%) as shown in Figure
3, the differences between groups A and B increased with
the severity of the initial clinical decompensation and was
reflected by the Killip classification.
Long-term clinical outcome. Mortality data was available
for 116 (99%) patients. (One patient was a visitor while he
experienced the qualifying AMI and was not available for
follow-up.) The average follow-up period was 30 6 10 (12.4
to 48) months and it did not differ between patients with
(group A) and those without early ST segment elevation
resolution (group B). As demonstrated by the Kaplan-Meier
curves for long-term survival in Figure 4, the absolute
difference of 9% in mortality which was noted between
group A and group B patients at the end of the hospital stay
persisted throughout the entire post-discharge follow-up
period. During the first year, eight (9%) patients died in
group A and five (18%) in group B, and during the entire
follow-up period, the mortality rates were 12% and 21%,
respectively (p 5 0.12 in log-rank test). When the relation
between early ST segment elevation resolution and long-
term (30 6 10 months) mortality was studied in a multi-
variate analysis, absence of early ST segment elevation
resolution was significantly associated with higher long-
term mortality (OR 5 7.3, 95% CI 2 to 29, p 5 0.0004 in
Cox proportional hazard regression analysis) and with one
year mortality (OR 5 14, 95% CI 2 to 99, p 5 0.0005 in
logistic regression analysis). In the final model, besides early
ST segment elevation resolution, age, pretreatment with
aspirin and treatment with catecholamines before the
PTCA were independent significant correlates of long-term
survival. Among the 25 patients who were presented with
cardiogenic shock, the long-term survival was 75% in those
who had early ST segment elevation resolution as compared
with only 20% in those who did not have early ST segment
elevation resolution, (p , 0.05) despite early angiographi-
cally successful primary PTCA in all patients. The 55
patients who were routinely followed in our outpatient clinic
were comparable with the entire study population with
respect to epidemiologic, clinical and hemodynamic baseline
characteristics and had similar angiographic and in-hospital
clinical results (data not presented). Absence of early ST
segment elevation resolution which occurred in 25% of
those patients was an independent predictor of a higher rate
of CHF during the follow-up period (50% vs. 27%, OR 5
6.5, 95% CI 1.3 to 33, p 5 0.016). The only two other
predictors of long-term CHF were the initial (ST segment
elevation (p 5 0.012) and angiotensin converting enzyme
(ACE) inhibitors administration (p 5 0.046). There were
no differences in the prevalence of reinfarction or reappear-
ance of angina.
Discussion. Primary PTCA was shown to be an effective
reperfusion strategy, which confers early restoration of
adequate coronary flow in more than 75% of the patients
(20,21). However, previous myocardial contrast echo
Figure 2. Prevalence of in-hospital adverse events in patients with
(group A) and without (group B) early ST segment elevation
resolution. *p 5 NS; **p 5 0.088. Solid bars 5 Group A; open
bars 5 Group B.
Figure 3. Comparison of in-hospital mortality and CHF in
patients with (group A) and without (group B) early ST segment
elevation resolution according to Killip classification on admission.
Solid bars 5 Group A; open bars 5 Group B.
Figure 4. Kaplan-Meier curves for long-term survival according to
the presence (solid line) or absence (dotted line) of early ST
segment elevation resolution (p 5 0.12 in log-rank test). Solid
line 5 Group A; dotted line 5 Group B.
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(MCE) studies demonstrated that, despite early restoration
of TIMI grade III flow in the IRA, myocardial reperfusion
may fail to occur in a substantial portion of the jeopardized
myocardium (7–13). This phenomenon was originally dem-
onstrated in animal models of ischemia and reperfusion and
was termed the “no-reflow” phenomenon (22,23). This
phenomenon is associated with extensive microvascular
damage (22–24) and with larger infarction (12,16,17),
poorer left ventricle (LV) functional recovery (7–
10,12,15,17), LV remodeling (12–16) and increased fre-
quency of CHF, malignant arrhythmias and myocardial
rupture (12,16). Thus, after primary PTCA, even if optimal
angiographic results are achieved, complete evaluation of
reperfusion success necessitate assessment of myocardial
reperfusion.
In this study we found that early ST segment elevation
resolution after angiographically successful primary PTCA
was associated with smaller myocardial damage and pre-
dicted better myocardial salvage and clinical outcome. The
more complete reperfusion in those with early ST segment
elevation resolution was also suggested by the different
impact of the Killip classification prior to the intervention
on the final outcome despite the similar angiographic
picture. As demonstrated by Figure 3, in patients without
early ST segment elevation resolution, the clinical outcome
deteriorated significantly with increase of Killip class,
whereas in those patients with early ST segment elevation
resolution, this trend was substantially attenuated.
Previous studies. Recently, Van’t Hof et al. (25) demon-
strated in a larger cohort, significant correlation between the
extent of ST segment elevation resolution within 1 h of
primary PTCA and reduction of the enzymatic infarct size,
improved LVEF and mortality. However, some differences
existed between the two studies: 1) due to differences in the
criteria used in triaging AMI patients for primary PTCA,
the patients included in this study represent a group of
higher risk patients who were more likely to have anterior
AMI (62% vs. 44%), previous MI (32% vs. 19%) and
diabetes mellitus (22% vs. 7%) and 18% of whom presented
with cardiogenic shock. This enabled us to show that the
prognostic value of early ST segment elevation resolution is
enhanced with the severity of the clinical status. 2) Van’t
Hof et al. (25) divided their patients into three groups
according to the extent of ST segment elevation resolution:
patients with complete resolution, partial resolution (at least
30% resolution) and no resolution. We demonstrated basi-
cally similar findings with a more simplified model of
patients differentiated into only two groups based on the
presence or absence of ST segment elevation resolution of at
least 50%.
In agreement with these findings, Kabayashi et al. (26)
showed that immediate ST segment elevation resolution
after angiographically successful primary PTCA, as com-
pared with the absence of immediate change in ST segment
elevation or further ST reelevation, predicted better LVEF
improvement and higher LVEF in the chronic phase of the
AMI. Similarly we recently showed that, in patients with
early peak CK after thrombolytic therapy as a marker of
early recanalization, rapid ST segment elevation resolution
identifies patients with better myocardial salvage (27). In
this study we suggested microvascular damage and the
“no-reflow” phenomenon as an explanation for the less
beneficial effect of angiographic reperfusion in patients
without early ST segment elevation resolution although this
mechanism has not been proven directly. Yet, previous
MCE studies showed that when the “no-reflow” phenom-
enon occurs as a complication of coronary intervention,
either during or not during AMI, it is accompanied by ST
segment elevation on the ECG (24,28,29).
Study limitations. We call for caution in interpreting the
results of our study due to the relatively small sample size.
Furthermore, several more specific, potential limitations of
this study should be considered. Although long-term mor-
tality data was available for 97% of the patients, information
regarding long-term CHF and recurrent ischemic events
was available only in 55 patients who were periodically
followed-up in our outpatient clinic.
However, a similar percentage of group A and group B
patients were followed-up so that patients with and without
ST segment elevation resolution were presented in identical
proportions in the entire population and among those who
were followed-up. Moreover, the 55 patients who were
routinely followed-up in our out-patient clinic had similar
baseline and angiographic characteristics, similar in-hospital
course and even similar long-term survival rates as compared
with the entire study population. This further decreased the
likelihood of severe selection bias.
An additional potential limitation is inherent in the study
design, to judge the presence of ST segment elevation
resolution based on the first ECG that was performed upon
return of the patients from the catheterization laboratory to
the ICCU and not after a predetermined constant time
period as is the custom after thrombolytic therapy. As a
consequence the time that elapsed between the first balloon
inflation and the performance of the ECG differed between
the patients. Probably more accurate information might
have been provided by continuous ECG recording. Yet, our
study design makes the results of this study directly appli-
cable to the routine clinical settings. Moreover, the average
time elapsed from the PTCA to the performance of the
post-PTCA ECG did not differ significantly between the
two study groups and therefore did not bias the results.
Clinical implication. In aggregate with previous studies,
our findings suggest that, after angiographically successful
primary PTCA, early ST segment monitoring provides
important information regarding the level of myocardial
reperfusion. We suggest that the use of a simple electrocar-
diographic marker, ST segment elevation resolution of at
least 50% in the early stages after primary PTCA in
combination with the angiographic results, provides more
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comprehensive evaluation of the quality of reperfusion and
improves the ability to predict the outcome of patients
post-primary PTCA. Such information may be important if
new adjunctive strategies will be available for treatment of
microvascular damage and improvement of myocardial
reperfusion.
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